• Thumbnail for Novartis
    Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one...
    142 KB (11,963 words) - 02:12, 21 May 2024
  • Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name...
    35 KB (2,761 words) - 04:02, 21 May 2024
  • Thumbnail for Ovaltine
    acquired the brand from Novartis in 2002, except in the United States, where Nestlé acquired the rights separately from Novartis in the late 2000s. Ovaltine...
    16 KB (1,674 words) - 07:01, 8 May 2024
  • Thumbnail for Alcon
    Alcon (category Novartis)
    2008, Novartis purchased approximately 25% of Nestlé's stake in Alcon, with an option to buy Nestlé's remaining shares beginning in 2010. Novartis bought...
    13 KB (959 words) - 15:17, 24 May 2024
  • Thumbnail for Vasant Narasimhan
    Vasant Narasimhan (category Novartis people)
    executive officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018. He briefly worked at McKinsey before joining Novartis in 2005, where he...
    22 KB (1,889 words) - 18:19, 23 May 2024
  • ease restrictions on the supply of Ritalin to help increase profits for Novartis. Beginning in the 1980s, a series of lawsuits were filed based on the perceived...
    8 KB (1,018 words) - 10:50, 19 December 2023
  • In February 2012, Novartis Consumer Health announced that they were temporarily, voluntarily suspending operations at the Novartis Consumer Health Lincoln...
    10 KB (1,153 words) - 19:14, 1 March 2024
  • Thumbnail for Imatinib
    Imatinib (category Drugs developed by Novartis)
    sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer...
    70 KB (6,513 words) - 09:10, 7 May 2024
  • subsequently "exited" by the company In September 2020, Novartis changed the company's name to Novartis Gene Therapies. Moore, Charles (7 May 2015). "John...
    9 KB (767 words) - 16:35, 12 May 2024
  • The Novartis-Drew Award for Biomedical Research is an award jointly presented by Novartis and Drew University. It comprises a cash award (originally $2000)...
    7 KB (586 words) - 17:23, 4 April 2024
  • global plant", Grimsby Telegraph, 16 August 2011, retrieved 23 August 2014 "Novartis Active Pharmaceutical Ingredients, United Kingdom", www.pharmaceutical-technology...
    78 KB (6,377 words) - 18:04, 27 February 2023
  • is the Country President for Australia and New Zealand for Novartis. Previously at Novartis he was the President of the Europe Central Cluster and Hungary...
    5 KB (442 words) - 19:34, 20 April 2024
  • Thumbnail for Novartis v. Union of India & Others
    Novartis v. Union of India & Others is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent...
    43 KB (5,296 words) - 20:23, 4 April 2024
  • The Novartis Foundation (formerly known as the Novartis Foundation for Sustainable Development) is a non-profit organization and part of the corporate...
    5 KB (488 words) - 07:51, 21 April 2024
  • to form Novartis. At Sandoz, he worked in research and development and became head of development in 1994. Following the merger into Novartis, Reinhardt...
    4 KB (368 words) - 15:01, 3 October 2023
  • combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed...
    23 KB (2,299 words) - 20:32, 15 April 2024
  • Thumbnail for Peter Piot
    Trustees Novartis Foundation. Novartis Foundation confirms new members of its Board of trustees, including new Chairman Dr. Joerg Reinhardt Novartis Foundation...
    34 KB (3,208 words) - 20:36, 17 March 2024
  • Onasemnogene abeparvovec (category Drugs developed by Novartis)
    whistleblower informed Novartis that certain studies of the medication had been subject to data manipulation. In a filing to the FDA, Novartis said that two executives...
    33 KB (2,442 words) - 16:44, 12 May 2024
  • Thumbnail for Excedrin (brand)
    majority ownership through a joint venture transaction with Novartis. On January 9, 2012, Novartis announced that it was voluntarily recalling all lots of...
    14 KB (1,378 words) - 01:18, 17 May 2024
  • Thumbnail for Pharmaceutical industry in Switzerland
    to many pharmaceutical companies, including very large groups, such as Novartis and Hoffmann-La Roche. In 2013, 41 life science companies had their international...
    10 KB (950 words) - 13:47, 16 May 2024
  • Thumbnail for Secukinumab
    Secukinumab (category Drugs developed by Novartis)
    arthritis. It binds to the protein interleukin (IL)-17A and is marketed by Novartis. Secukinumab is used to treat psoriasis, ankylosing spondylitis, and psoriatic...
    15 KB (1,152 words) - 06:14, 7 April 2024
  • Thumbnail for Joseph Jimenez
    Joseph Jimenez (category Novartis people)
    an advisor for the Blackstone Group. Jimenez joined Novartis in 2007 as Division Head of Novartis Pharmaceutical and was named CEO in 2010 by his predecessor...
    8 KB (599 words) - 15:32, 19 December 2023
  • the 1990s by researchers at Chiron Corporation, a Novartis heritage company, acquired by Novartis in 2006. AS03, another squalene based adjuvant O’Hagan...
    2 KB (236 words) - 19:26, 3 February 2023
  • com. "Novartis Financial Results Q4 2023" (PDF). "Novartis Financial Results Q4 2022" (PDF). Media release 2021 Novartis Media release 2019 Novartis Media...
    61 KB (2,701 words) - 11:52, 23 April 2024
  • Artemether/lumefantrine (category Drugs developed by Novartis)
    supplies of Coartem met demand which enabled Novartis to further decrease the price of Coartem. In April 2008, Novartis further reduced the public sector price...
    12 KB (1,164 words) - 01:18, 21 April 2024
  • premium. On January 22, 2018, Novartis AG announced the successful completion of the tender offer by its subsidiary, Novartis Groupe France S.A. AAA was...
    17 KB (1,540 words) - 20:14, 20 August 2022
  • Thumbnail for Switzerland
    Basel is the capital of Switzerland's pharmaceutical industry, hosting Novartis, Roche, and many other players. It is one of the world's most important...
    235 KB (20,253 words) - 20:23, 26 May 2024
  • Thumbnail for Lifitegrast
    Lifitegrast (category Drugs developed by Novartis)
    Company in late 2018. In May 2019 Novartis reached an agreement to purchase the assets associated with Lifitegrast. Novartis will pay Takeda an upfront payment...
    8 KB (575 words) - 05:41, 13 April 2024
  • The company is located in Mississauga, Ontario. It is a subsidiary of Novartis. The company was founded in 1919 by William Knapp Buckley (1890 - 1978)...
    3 KB (355 words) - 05:03, 21 February 2024
  • on emerging markets. In April 2014, Novartis and Glaxo agreed on more than US$20 billion in deals, with Novartis selling its vaccine business to GSK and...
    136 KB (12,184 words) - 16:16, 25 May 2024